BMO Capital Initiates Coverage On Conmed with Market Perform Rating, Announces Price Target of $36

Benzinga Newsdesk www.benzinga.com Positive 57.4%

Neg 0% Neu 0% Pos 57.4%

BMO Capital initiates coverage on Conmed (NYSE:CNMD) with a Market Perform rating and announces Price Target of $36.

Comments

No comments yet. Be the first!